Investigating the Effects on Modelling & Dosing When Expanding into ADC Combinations
Time: 9:30 am - 12:30 pm
day: Pre-Conference Workshop Day
Details:
Join this workshop to explore how next generation dosing strategies can unlock the full potential of ADC combination therapies. There is no silver bullet for treatment, and combinations are widely considered the next step in oncology treatment, so in this workshop you’ll dive into the latest thinking, tools, and translational tactics that are reshaping combination regimens. Gain practical insights and forward-looking perspectives to help bring more potent, precise, and patient-centered ADC combinations to the clinic.
- Driving smarter ADC combination designs with preclinical data and clinical signals
- Fine-tune exposure, manage additive toxicities, and amplify efficacy with brand-new strategies
- Predicting the best dose, schedule, and combination partner for your ADC using PK/PD modelling
- Personalized combination regimens for different tumor types and patient populations
- Tackling drug-drug interactions, shifting PK profiles, and translational disconnects
- Building clinical protocols that balance benefit and risk in first-in-combo trials
